Graft-versus-host disease (GVHD) is a potential post-transplant complication. Here’s how one patient and his wife are ...

The ASH meeting included positive early results about a Terns drug for chronic myeloid leukemia and a Kura menin-blocker for ...

At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, ...

What is Acute Myeloid Leukemia? Acute myeloid leukemia is a severe form of cancer that originates in the bone marrow, where new blood cells are generated. According to the American Cancer Society, AML ...

A new drug that treats adults with acute myeloid leukemia, and three years after Roswell enrolled the first patient to use ...

A new leukemia drug has been approved by the FDA. Roswell Park had recently done a clinical trial on the drug.

Hardee Bhavsar ran her first marathon in November, five years after being diagnosed with lymphoma. She recalls the early ...

TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal protein plays an important role in the development of AML because it prevents ...

First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability among primarily R/R NPM1m, KMT2Ar, and NUP98r acute leuk ...

Chemical industry lobbyists have long pushed the government to adopt a less stringent approach to gauging the cancer risk ...